Related Experiment Video

Updated: Jun 4, 2026

Initiation of Metastatic Breast Carcinoma by Targeting of the Ductal Epithelium with Adenovirus-Cre: A Novel Transgenic Mouse Model of Breast Cancer
07:13

Initiation of Metastatic Breast Carcinoma by Targeting of the Ductal Epithelium with Adenovirus-Cre: A Novel Transgenic Mouse Model of Breast Cancer

Published on: March 26, 2014

Antisense Tumor Therapy : Activated C-Ha-ras Oncogene in the Mouse

E Wickstrom1

  • 1Department of Pharmacology, Thomas Jefferson University, Philadelphia, PA.

Methods in Molecular Medicine
|March 2, 2011
PubMed

Insights

Cancer cells activate normal genes called proto-oncogenes, like the ras family, which drive cell proliferation. Targeting these activated genes is crucial for treating cancers such as solid tumors and leukemias.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Cancer cells exhibit altered expression of genes involved in normal cell proliferation.
  • These genes, known as proto-oncogenes, can become activated through mutations or overexpression.
  • The ras family of proto-oncogenes (Ha-ras, Ki-ras, N-ras) is frequently implicated in human cancers.

Purpose of the Study:

  • To highlight the role of proto-oncogenes in cancer development.
  • To identify activated cellular genes as key targets for neoplastic cell therapy.
  • To emphasize the frequent activation of the ras family of proto-oncogenes in human malignancies.

Main Methods:

  • Review of existing literature on proto-oncogenes and cancer.
  • Analysis of gene expression patterns in cancerous cells.
  • Identification of frequently activated gene families in human tumors.

Main Results:

  • Proto-oncogenes are identified as critical players in cancer cell proliferation.
  • The ras family, including Ha-ras, Ki-ras, and N-ras, shows high activation rates in human solid tumors and leukemias.
  • Activated cellular genes represent viable therapeutic targets in neoplastic diseases.

Conclusions:

  • Targeting activated proto-oncogenes, particularly the ras family, is a promising strategy for cancer therapy.
  • Understanding proto-oncogene activation is fundamental to developing effective cancer treatments.
  • The ras family's frequent involvement underscores its significance in oncogenesis.

More Related Videos

In Vitro Establishment of a Genetically Engineered Murine Head and Neck Cancer Cell Line using an Adeno-Associated Virus-Cas9 System05:45

In Vitro Establishment of a Genetically Engineered Murine Head and Neck Cancer Cell Line using an Adeno-Associated Virus-Cas9 System

Published on: January 9, 2020

In Vivo CRISPR/Cas9 Screening to Simultaneously Evaluate Gene Function in Mouse Skin and Oral Cavity07:52

In Vivo CRISPR/Cas9 Screening to Simultaneously Evaluate Gene Function in Mouse Skin and Oral Cavity

Published on: November 2, 2020

Related Concept Videos

Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...